On the one hand, the prognostic relevance of PAI-1 overexpression may be related to its inhibitory effect on profibrinolytic plasmin associated with hypo-fibrinolytic conditions, which is commonly seen in patients with liver malignancies with venous thromboembolic complications [30]. The gene discussed is PLG; the disease is complication.